Sysmex Corporation

04/02/2024 | Press release | Distributed by Public on 04/01/2024 19:11

Soluble Immune Checkpoint Factors in Blood as Potential Biomarkers of Therapeutic Efficacy for ICI Cancer Immunotherapy and Assessing T-cell Exhaustion